🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Avery Feit

Dana-Farber Cancer Institute

ORCID: 0000-0002-6586-9052
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer”.

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-23-1711
N/A
0.596DataRank · unranked
15 citations

Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi +36 more

Combination of fulvestrant and chemotherapy in ESR1 Y537S mutant breast cancer cells and potential synergy mechanism related to p53 wildtype.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1065
N/A
0DataRank · unranked
1 citations

Francisco Hermida‐Prado, Cristina Guarducci, Avery Feit, Agostina Nardone, Gabriella Cohen +6 more

CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis

Genomics Proteomics & Bioinformatics(2021)10.1016/j.gpb.2020.11.007
N/A
0DataRank · unranked
39 citations

Avery Feit, Ariel Feiglin, Yingtian Xie, Nikolas Kesten, Len Taing +10 more

CoBRA: Containerized Bioinformatics workflow for Reproducible ChIP/ATAC-seq Analysis - from differential peak calling to pathway analysis

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.06.367409
N/A
0DataRank · unranked
4 citations

Avery Feit, Ariel Feiglin, Yingtian Xie, Nikolas Kesten, Len Taing +10 more

A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.29.486217
N/A
0DataRank · unranked
1 citations

Xintao Qiu, Ariel Feiglin, Xiaoyong Fu, Sándor Spisák, Avery Feit +20 more

Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2975
N/A
0DataRank · unranked
35 citations

Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Héraud, Albert Grinshpun +26 more

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Nature Communications(2022)10.1038/s41467-022-30257-z
N/A
0DataRank · unranked
160 citations

Nadia Boufaied, Tarek Hallal, Avery Feit, Anna de Polo, Adrienne Luoma +30 more